The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
zavegepant · Powder
1 marketed package NDCs · 1 active manufacturer
Most dispensed: HYDROCHLORIDE 10 mg/.1mL · Spray · #6 blister packs/carton / 1 vial, single-dose in 1 blister pack / .1 ml in 1 vial, single-dose
What changed in the last 90 days
Every detected change for zavegepant, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
Same drug class
Other molecules FDA puts in Calcitonin Gene-related Peptide Receptor Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Zavegepant in shortage right now?
- No. FDA does not currently list Zavegepant in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Zavegepant?
- 4 companies have marketed Zavegepant in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Zavegepant cost?
- The typical pharmacy pays about $189.83 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.